Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Novelix Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 24th June, 2025 at the Registered office of the Company, to discuss the following: 1. To consider and approve the conversion of Warrants into Equity Shares of the Company; 2. Any other matter with the permission of chair.
The above information is a part of company’s filings submitted to BSE.
